Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-lipoic Acid in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06067698Completed
- Sponsor
- Tanta University
- Start
- Oct 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in ulcerative colitis (UC) comparing Group (Placebo) with Group (Alpha lipoic acid) (2 arms). Primary endpoints: Health Related Quality of Life at 3 months and Disease Severity at 3 months. Started Oct 2023; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06067698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06067698.